http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004534830-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2002-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004534830-A |
| titleOfInvention | Nucleoside compounds in HCV |
| abstract | Formula (I) [wherein, X is H, F, N 3, NH 2, shows a -CN or -OMe; X 1 represents O or NR 7; X 2 is O, NH, a NR 6 or S Shown, or when X 3 is O, X 2 is absent; when X 3 is absent or X 1 is O, X 3 represents O; R 1 is hydrogen; Optionally substituted C 1-6 alkyl; optionally substituted aryl; or optionally substituted heteroaryl; R 2 represents hydroxy, OCOR 6 or OCO 2 R 6 ; R 3 is H, substituted Represents optionally substituted C 1-6 alkyl, optionally substituted aryl, optionally substituted heteroaryl or optionally substituted heterocyclyl; R 4 and R 5 are independently hydrogen, C 1-6 alkyl optionally substituted R 6 represents an optionally substituted C 1-6 alkyl or an optionally substituted aryl; R 7 represents an optionally substituted aralkyl or an optionally substituted aralkyl; H, optionally substituted C 1-6 alkyl, or optionally substituted aryl, wherein when R 4 and R 7 are each alkyl, they are bonded to 5- or 6- B may represent (a), (b), (c) or (d), wherein Z represents O or S; R 8 is H, halo, C 2 -4 alkynyl, trifluoromethyl, C 1-3 alkoxy, shown hydroxy, methylthio, amino, nitro or C 1-3 alkyl substituted, here, C 1-3 alkyl hydroxy, halo, by an amino or oR 10 Well even if, here, R 10 represents itself optionally substituted substituted by aryl optionally C 1-6 alkyl; R 9 is H, halo, hydroxy, OR 6, SR 6 or NR 3 R 3 ] are useful in the treatment of viral infections, especially HCV infections. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010515680-A |
| priorityDate | 2001-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 123.